Healthy skin depends on a unique lipid profile to form a barrier that confers protection and prevents excessive water loss, aids cell-cell communication and regulates cutaneous homoeostasis and inflammation. Alterations in the cutaneous lipid profile can have severe consequences for skin health and have been implicated in numerous inflammatory skin conditions. Thus, skin lipidomics is increasingly of interest, and recent developments in mass spectrometry-based analytical technologies can deliver in-depth investigation of cutaneous lipids, providing insight into their role and mechanism of action. The choice of tissue sampling technique and analytical approach depends on the location and chemistry of the lipid of interest. Lipidomics can be conducted by various mass spectrometry approaches, including different chromatography and ionisation techniques. Targeted mass spectrometry is a sensitive approach for measuring low-abundance signalling lipids, such as eicosanoids, endocannabinoids and ceramides. This approach requires specific extraction, chromatography and mass spectrometry protocols to quantitate the lipid targets. 
| INTRODUC TI ON
The skin is a site of complex and unique lipid metabolism, with lipids essential to cutaneous function and dependent on dietary provision. [1, 2] From fatty acyls to more complex glycerolipids, glycerophospholipids, sphingolipids and sterols, the lipid classes found in skin cover a range of chemistries and perform niche roles within the organ. [3, 4] Sebum on the skin's surface predominantly comprises triacylglycerols, wax esters, squalene and free fatty acids;
lipid species that help to waterproof the skin, contribute to barrier function, but also support and regulate cutaneous microbiota. [5, 6] An equimolar ratio of ceramides, cholesterol and free fatty acids forms the epidermal lipid barrier in the stratum corneum and is responsible for preventing excessive trans-epidermal water loss (TEWL) and ion permeability. [7] The lipids found in skin cell membranes, predominantly glycerophospholipids, sphingomyelins and cholesterol, play important roles in protein function, cell mobility and cell-cell communications. [8] [9] [10] Importantly, membrane lipids also undergo active metabolism to bioactive lipid mediators, including eicosanoids, endocannabinoids and ceramides, which regulate numerous physiological processes in skin homoeostasis and inflammation, including immune cell mobility and function, [11] [12] [13] vasodilation and relaxation, [14, 15] and keratinocyte and fibroblast proliferation, differentiation and migration. [16] [17] [18] Cutaneous lipid metabolism results in a continuous flux of bioactive lipid species, and the increasing appreciation of the translational role of skin lipidomics has driven developments in lipidomic technologies. In order to obtain the maximum amount of information relevant to skin lipid biology, it is important to use bioanalytical approaches capable of identifying and quantitating across the range of lipids.
Here, we present a review of the main technology platforms currently used in skin lipidomics and provide examples of the amount and variety of lipidomic information that can be obtained from skin biopsies using these techniques, including targeted mass spectrometry, untargeted mass spectrometry and mass spectrometry imaging.
| S K IN LIPID SAMPLING AND E X TR AC TI ON
Skin lipid analysis requires appropriate lipid sampling, extraction and analysis, which depend on the skin compartment of interest, the chemistry of the target lipids and the information required, respectively. Examples of different approaches are shown in 
| Skin lipid sampling
The choice of skin lipid sampling is determined by the location of the cellular target within the skin. Surface lipids found in sebum or stratum corneum can be captured using non-invasive tape strips.
Tapes designed to absorb sebum lipids (eg Sebutape ® [19] ) or remove stratum corneum (eg D-Squame ® [20] ) can be treated with solvents to yield epidermal lipids. [21] [22] [23] Tape strips have been used to sample consecutive non-viable stratum corneum layers and provide information on lipid species found at different stratum corneum depth, [24] but deeper sampling is needed to examine viable cells.
If lipids from the dermis are also required, the most appropriate sampling approach is the full-thickness skin biopsy. Biopsies can be split to allow separate analyses of the different skin compartments, or used for lipid imaging to analyse the full cross-section of the biopsy. [25, 26] A third option is suction blister fluid sampling. [27] This involves applying vacuum to the skin to raise a suction blister, followed by aspiration of the blister fluid that contains lipid mediators of primarily epidermal origin. [28] Other types of samples that can be used to study cutaneous lipid biology include the vernix caseosa [29] and sweat. [30, 31] Sample preparation is important, as rapid degradation or metabolism of lipids is possible posttissue-harvesting. Ideally, skin samples (biopsies, blister fluid or tape strips) should be flash-frozen in liquid nitrogen immediately after harvesting. Samples should then be stored at −80°C prior to analysis.
| Lipid extraction
Lipid extraction primarily relies on solvents to disrupt cellular membranes and solubilise lipids. Solvents are selected based on the chemistry of the lipids being analysed and vary depending on the polarity of the target lipids (this has been reviewed recently [32] ). Whilst F I G U R E 1 Schematic representation of skin lipidomics workflow. Several mass spectrometry-based lipidomics approaches are available for the investigation of the skin lipidome. A combination of these platforms can reveal the most information about skin lipids. 3Q, triple quadrupole; DESI, desorption electrospray ionisation; ESI, electrospray ionisation; IS, internal standards; MALDI, matrix-assisted laser desorption ionisation; RPC, reverse-phase chromatography; UHPSFC, supercritical fluid chromatography tape-stripped stratum corneum and epidermal blister fluid samples can be added directly to solvents, [20, 33] biopsy samples require homogenisation to disrupt the tissue and maximise lipid extraction. [34] Some extraction protocols involve further purification of lipids, such as solid-phase extraction, methylamine or alkaline hydrolysis, to remove contaminants and reduce matrix effects that can impede the analysis; this is particularly important when targeting lipid species found in low abundance. [35] [36] [37] Lipid imaging approaches (discussed in Section 4) such as matrix-assisted laser desorption ionisation (MALDI) mass spectrometry imaging (MSI) and desorption electrospray ionisation-MSI (DESI-MSI) require no initial extraction steps, as lipids are ionised directly from the tissue sample.
The amount of lipid extracted can be normalised against tissue wet weight, dry weight, sample volume, protein content, phosphate or cholesterol. [28, 38, 39] Most lipid extraction protocols allow the retention of proteins from the sample, for later analysis of protein content. However, consideration must be given to how cutaneous changes might influence the sample protein content. For example, diseased skin may display different levels of cell cohesion compared with healthy skin, resulting in the collection of a different number of cells when using tape strips. [40] In these cases, it may be more appropriate to report total lipids per surface area. Additionally, certain treatments may alter the protein content of blister fluid, so normalisation by fluid volume may be more appropriate.
[41]
| S K IN LIPID ANALYS IS
Although approaches such as enzyme-linked immunosorbent assays (ELISA) can be used to quantitate some lipid mediators (eg prostaglandins), there are limitations of these methods. ELISA can only detect a single lipid species at a time, although are often unable to differentiate between isomeric species, resulting in considerable cross-reactivity. [42] Additionally, discovery of new lipid species is impossible with ELISA, and limited lipid targets are available. Some of the analytical approaches used in lipid analysis, including nuclear magnetic resonance and gas chromatography, can offer some insight into skin lipid biology, but there are limitations in their compound coverage, sensitivity and efficiency. [43] Developments in mass spectrometry and chromatography have accelerated lipidomic analytical capabilities, allowing accurate identification and quantitation of complex mixtures of lipids. [44] Mass spectrometry covers a range of analytical capabilities that can be selected depending on the lipids of interest, relying on the identification of lipids based on their ionisation and molecular fragmentation patterns. Although some lipid species are analysed following untargeted shotgun approaches, [20] quantitative lipidomics are performed using mass spectrometry paired with chromatography to separate lipid components prior to their analysis, to maximise sensitivity. Complex lipid mixtures found in skin benefit from appropriate separation to improve the analytical sensitivity, minimise matrix effects and ion suppression and inform peak identification. [45] It is important to consider both the quantity and proportion of lipids present in the skin. For example, aged skin appears to contain lipids in the same proportions as young skin, but overall levels are reduced, [46] whereas atopic dermatitis skin demonstrates changes in both the overall level of cutaneous ceramides and the proportion of different ceramide families. [47] Such detailed investigations require accurate lipid identification and quantitation, and a range of mass spectrometry-based lipidomics approaches are available for consideration.
| Chromatography
Chromatography is used to separate different lipid classes (or lipid species) found in a sample following their extraction from tissue; the choice of chromatography depends on the lipids of interest and their physicochemical properties. Cutaneous lipids are a diverse family of hydrophobic, low molecular weight compounds, with a range of polarities and considerable structural similarity within each lipid class. [48] These aspects complicate both lipid separation and analysis, and often different approaches will be required to fully interrogate skin lipid biology.
Normal-phase chromatography separates complex lipids based on the functionality of the polar head group, which results in similar retention times for members of the same lipid class, making distinction between lipid isomers extremely difficult, although linear separation by molecular weight is possible. [49] Normal-phase chromatography also allows the rapid elution of extremely hydrophobic compounds, such as acylceramides, which is not always possible in reverse-phase chromatography. [50] Reverse-phase chromatography separates lipids based on their fatty acyl components (different chain length and number of double bonds), resulting in co-elution of different lipid classes, but allowing separation of isomers within the same lipid class. [51] Supercritical fluid chromatography is a hybrid of normal-and reverse-phase liquid chromatography, offering separation of molecules with a broad range of polarities in a single chromatographic run. [52] Consequently, this is a useful approach for the untargeted analysis of complex mixtures of skin lipids, including glycerolipids, glycerophospholipids, sterols and free fatty acids, as hydrophilic, hydrophobic and polar lipid species can be separated based on both their fatty acyl moieties and their polar head groups;
this is useful for classes with similar hydrophobicities such as triacylglycerols and cholesteryl esters, which are important in skin. [52] [53] [54] [55] [56] 
| Mass spectrometry
Whether direct infusion or chromatographic introduction is used, there are various mass spectrometry platforms available for lipidomics applications (recently reviewed in ref. [44] ). Extracted lipids must be ionised and introduced into the mass spectrometer for analysis.
The preferred ionisation method for most lipids is electrospray ionisation (ESI). An electric potential applied to a nebulised sample solution results in a fine spray, forming ions upon desolvation. [57, 58] ESI is considered to be a softer ionisation technique than other popular approaches and provides a reliable tool for obtaining molecular mass information in lipidomics. [59] Other common lipid ionisation methods include MALDI and DESI (discussed in Section 4). [44] DESI is a derivative of ESI, in which spatial distribution of lipids in the sample can QToFs and ToF-ToFs). [60] These approaches can provide information about both precursor and product ions, enabling more confident peak identification, and this method of detection is particularly recommended for complex mixtures such as skin lipid extracts.
| Targeted mass spectrometry
Targeted mass spectrometry can be used to investigate a particular This approach has been used to generate information about bioactive lipid mediators in skin, including eicosanoids and related species, endocannabinoids and other N-acyl ethanolamines. [28, 34, [61] [62] [63] As many of these pathways and lipid classes have been well elucidated, individual species can be analysed using a targeted approach, and, by limiting the range of lipids being analysed, sensitivity is maximised, which is important given that these lipids are usually present in low abundance. [42] Another set of cutaneous lipids that can be analysed using targeted lipidomics is the ceramide family, a group of lipids that are essential components of the epidermal lipid barrier. [64] Although ceramides are found throughout the body, the skin contains unique acylceramides with an additional linoleic acid subgroup, and these are formed within the epidermis. [65] [66] [67] Ceramides have been implicated in diseases of epidermal barrier dysfunction, including psoriasis, [68] atopic dermatitis [47] and ichthyosis, [69] and so are of clinical interest. The analysis of ceramides has progressed from simple, thin-layer chromatography, which provides total ceramide content or analysis of the ceramide classes found in skin lipid extracts, including the complex acylceramides, through qualitative identification of individual species, to accurate identification and quantitation or semiquantitation of more than 320 ceramide species using multiple reaction monitoring by MS/MS. [23, 47, 50, 64, [70] [71] [72] [73] [74] Preliminary targeted analysis of epidermal and dermal ceramides performed by assays developed in our group (Appendix S1) reveals differences in the profiles of the two skin compartments ( Figure 2D ). The most obvious difference is the absence of acyl- this analysis necessitates more sample as the extraction protocols of low-abundance species, such as the eicosanoids, requires a different extraction protocol optimised for this lipid class. [28, 34] Such low-abundance, short-lived lipid mediators are unlikely to be identified by untargeted analyses or lipid imaging, so targeted mass spectrometry remains the most appropriate platform for their analysis.
ceramides (CER[EOH], CER[EOS] and CER[EOP]) in the dermis
Commercial availability of synthetic standards and deuterated internal standards permits the use of calibration lines for quantitation, and the resulting assays can reveal disease-or treatment-induced changes in specific lipid pathways. [33, 34, 73] 
| Untargeted mass spectrometry
Untargeted lipidomics can provide a useful and rapid approach to identify global changes in lipid profiles, as well as discover novel lipid species. Although restrictions include limited identifications due to the large number of lipid species being analysed and reduced sensitivity, hundreds of lipid species can be identified and semiquantitated in one analytical run. [45, 75] One of the simplest and fastest data acquisition modes for untargeted lipidomics is MS E , which involves detection of molecules within a given mass-to-charge ratio (m/z) range applying alternating low and high collision energies, using hybrid mass spectrometers such as QToF that provide accurate mass information to allow the identification of co-eluting lipid analytes.
In this approach, fragment ions are formed in an untargeted manner, revealing precursor and product ions that can be matched by 
| MA SS S PEC TROME TRY LIPID IMAG ING
The mass spectrometry approaches described above rely on the extraction of lipids from tissue prior to analysis. However, this means that detailed anatomical information about the location of lipids or lipid changes within skin is lost upon homogenisation of the tissue.
Another option for skin lipid analysis is mass spectrometry imaging (MSI). This allows the direct sampling of lipid ions from the skin tissue, without prior extraction, so that lipids can be analysed in situ. [76] While direct ionisation techniques such as MALDI and DESI can be used for homogenised samples, they have also proved useful in providing spatial distribution information through skin imaging analysis. [26, [77] [78] [79] [80] A full-thickness skin biopsy can be sectioned onto a glass slide, and by placing the sample on a moving stage, the mass spectrometer samples ions as it performs spot-to-spot analysis, or rasters, across the skin tissue, allowing reconstruction of an image of the full-thickness skin representing ion intensities. [81] For each pixel with given x and y coordinates, a mass spectrum is recorded with information on m/z and ion abundance. By selecting an ion of interest and extracting the data for each pixel, a chemical map of the tissue can be built-up, showing the distribution and abundance of that lipid molecular ion across the sample. [82, 83] This provides information on the different skin compartments in one image, revealing anatomical lipid distribution, as well as allowing semiquantitative comparison of lipid intensities between samples, and the MSI data can be coregistered with the same or a consecutive section that has undergone histochemical staining. [26, 77] The size of the pixels and the ions sampled depends on the ionisation approach, and MALDI and DESI offer different advantages.
| MALDI
MALDI-MSI involves coating the tissue with a matrix that promotes ionisation of the lipid species [84, 85] and has been used to study lipid changes in skin and skin equivalents. [26, 77, 78] MALDI-MSI can provide very good spatial resolution depending on the laser spot size on the surface, with small pixel sizes of 15 μm obtainable using commercial systems, [86] but analysis requires special consideration of sample preparation, including matrix application, which depends on factors such as the target ions (recently reviewed in ref. [87] ). An important consideration of matrix selection is the spectrum of matrix-derived ions and whether these interfere with the compounds of interest.
Examples of matrices that are used for lipid analysis include α-cyano-4-hydroxy-cinnamic acid (CHCA) and 9-aminoacridine (9AA). [88] CHCA typically produces ions below m/z 500, [89] so these do not interfere with most lipid species of interest in skin, including phospholipids and acylglycerols. [85] 9AA is commonly used in negative mode and produces low m/z ions (majority below m/z 300), [90] which would not interfere with lipids typically identified in negative mode, including phosphatidylglycerols and phosphatidic acids.
| DESI
DESI allows ionisation of lipids directly from skin tissue under ambient conditions by directing an electrically charged fine spray of an appropriate solvent at the tissue sample, and sampling the ionised lipids directly into the mass spectrometer. [91] Unlike MALDI-MSI, no matrix is required, so skin tissue simply requires sectioning prior to analysis. DESI-MSI has proven capabilities in imaging of lipids across tissues, [92] [93] [94] but until recently has lacked the spatial resolution to analyse intricate tissues such as skin, with typical pixel sizes around 100 μm. [82, 83, 86] These examples were chosen from untargeted analysis because of clear differences across the tissue in this preliminary study, but targeted approaches examining specific lipids of interest can also be performed using both MALDI-MSI and DESI-MSI. inflammatory skin conditions such as sunburn [61, 62] and irritant dermatitis, [34] to the effects of topical treatments and nutritional supplementation on the skin lipidome, [33, [95] [96] [97] [98] [99] revealing biomarkers, unravelling complex signalling pathways and identifying potential therapeutic targets. As mass spectrometry technology continues to improve, resulting in increased mass accuracy, sensitivity, spatial resolution and more, we expect skin lipidomics to become a routine consideration in the investigation of cutaneous homoeostasis and inflammation. 
| Skin biopsy analysis
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